Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
27/03/2025 15:29
March 27 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd 1558.HK: ENCOFOSBUVIR TABLETS (0.3G) APPROVED FOR LAUNCH BY NMPA Further company coverage: 1558.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million